FAST TRACK FOR DRUG SLOWING ALZHEIMER'S!
National Enquirer|February 13, 2023
A NEW drug to treat Alzheimer's disease was fast-tracked for approval by the U.S. Food and Drug Administration (FDA), arming physicians with another weapon in their fight against the memory robbing condition! Lecanemab, which is being marketed as Leqsebi, is not a cure.
FAST TRACK FOR DRUG SLOWING ALZHEIMER'S!

But it appears to slow disease progression by reducing amyloid-beta plaque damaging protein clumps found in the brains of folks with Alzheimer's.

Dr. Billy Dunn, director of the FDA's Office of Neuroscience, says, "This is the latest therapy to target and affect the underlying disease process instead of only treating the symptoms."

هذه القصة مأخوذة من طبعة February 13, 2023 من National Enquirer.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.

هذه القصة مأخوذة من طبعة February 13, 2023 من National Enquirer.

ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.